Polymerase-guided base editing enables in vivo mutagenesis and rapid protein engineering.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33707425.
- Also identified by DOI 10.1038/s41467-021-21876-z and PMC identifier 7952560.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Random mutagenesis is a technique used to generate diversity and engineer biological systems. In vivo random mutagenesis generates diversity directly in a host organism, enabling applications such as lineage tracing, continuous evolution, and protein engineering. Here we describe TRIDENT (TaRgeted In vivo Diversification ENabled by T7 RNAP), a platform for targeted, continual, and inducible diversification at genes of interest at mutation rates one-million fold higher than natural genomic error rates. TRIDENT targets mutagenic enzymes to precise genetic loci by fusion to T7 RNA polymerase, resulting in mutation windows following a mutation targeting T7 promoter. Mutational diversity is tuned by DNA repair factors localized to sites of deaminase-driven mutation, enabling sustained mutation of all four DNA nucleotides at rates greater than 10<sup>-4</sup> mutations per bp. We show TRIDENT can be applied to routine in vivo mutagenesis applications by evolving a red-shifted fluorescent protein and drug-resistant mutants of an essential enzyme.
Medical subject headings
- DNA-Directed RNA Polymerases
- Directed Molecular Evolution
- Drug Resistance, Fungal
- Protein Engineering
- Saccharomyces cerevisiae
- Saccharomyces cerevisiae Proteins
- Viral Proteins